COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,302 Articles (22,772 medRxiv, 8,530 bioRxiv)

Most recent first Previous |  Page 2599: Articles 25981-25990  | Next

The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2
Sacramento, C. Q., Fintelman-Rodrigues, N., Temerozo, J. R., da Silva Gomes Dias, S., Ferreira, A. C., Mattos, M., Pao, C. R. R., de Freitas, C. S., Cardoso Soares, V., Bozza, F. A., Bou-Habib, D. C., Bozza, P. T., Souza, T. M. L.
10.1101/2020.06.15.153411 — Posted: 2020-06-16
Comparative analysis of coronavirus genomic RNA structure reveals conservation in SARS-like coronaviruses
Sanders, W., Fritch, E. J., Madden, E. A., Graham, R. L., Vincent, H. A., Heise, M. T., Baric, R. S., Moorman, N. J.
10.1101/2020.06.15.153197 — Posted: 2020-06-16
The IMEx Coronavirus interactome: an evolving map of Coronaviridae-Host molecular interactions
Perfetto, L., Pastrello, C., Del-Toro, N., Duesbury, M., Iannuccelli, M., Kotlyar, M., Licata, L., Meldal, B., Panneerselvam, K., Panni, S., Rahimzadeh, N., Ricard-Blum, S., Salwinski, L., Shrivastava, A., Cesareni, G., Pellegrini, M., Orchard, S., Jurisica, I., Hermjakob, H., Porras, P.
10.1101/2020.06.16.153817 — Posted: 2020-06-16
Predicting mammalian hosts in which novel coronaviruses can be generated.
Wardeh, M., Baylis, M., Blagrove, M. S.
10.1101/2020.06.15.151845 — Posted: 2020-06-16
Cell entry of SARS-CoV-2 conferred by angiotensin-converting enzyme 2 (ACE2) of different species
Tang, Y.-D., Li, Y., Sun, J., Zhang, H., Wang, T.-y., Sun, M.-X., Yang, Y.-L., Hu, X., Zhao, J., Cai, X.
10.1101/2020.06.15.153916 — Posted: 2020-06-16
Catch and kill airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system
Yu, L., Peel, G. K., Cheema, F. H., Lawrence, W. S., Bukreyeva, N., Jinks, C. W., Peel, J. E., Peterson, J. W., Paessler, S., Hourani, M., Ren, Z.
10.1101/2020.06.13.150243 — Posted: 2020-06-16
COVID-19-related coagulopathy, is transferrin a missing link?
McLaughlin, K.-M., Bechtel, M., Bojkova, D., Ciesek, S., Wass, M. N., Michaelis, M., Cinatl, J. N.
10.1101/2020.06.11.147025 — Posted: 2020-06-16
COVID-19 IN INDIA: MODELLING, FORECASTING AND STATE-WISE COMPARISON
Jose, A., Salim, A., George, N., Subhash, S.
10.1101/2020.06.15.20131375 — Posted: 2020-06-16
Cumulative effect of aging and SARS-CoV2 infection on poor prognosis in the elderly: Insights from transcriptomic analysis of lung and blood
Bhattacharyya, U., Thelma, B.
10.1101/2020.06.15.151761 — Posted: 2020-06-16 Discussion: Onsite
Innate immune signaling in the olfactory epithelium reduces odorant receptor levels: modeling transient smell loss in COVID-19 patients
Rodriguez, S., Cao, L., Rickenbacher, G. T., Benz, E. G., Magdamo, C., Ramirez Gomez, L. A., Holbrook, E., Dhilla Albers, A., Gallagher, R., Westover, M. B., Evans, K. E., Tatar, D., Mukerji, S., Zafonte, R., Boyer, E. W., Yu, C. R., Albers, M. W.
10.1101/2020.06.14.20131128 — Posted: 2020-06-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).